Month: March 2014

The optimism and hope of a stable Government coupled with macro-economic parameters has led to Foreign Institutional Investors shoring up Indian Equities. The strengthening of Indian rupee and confidence in the new RBI governor’s policies and outlook, receding macro concerns like CAD, lower inflation and fiscal deficit numbers. More importantly, they seem to be looking at the overall GEMS market and India looks far better than any of the other members in the BRICS – China has its own issues, especially the banking system, where no one seems to believe the numbers and most investors perceive stress is very high, Russia and Brazil are not favoured, and more importantly.

If there is any further rally after a favourable election verdict, a (more…)

Economic Rsearchers have been able to establish definite co-relation between Congress Government’s flawed Policy and the Labour Market and thus its impact on the Inflation. Rural wages have been growing by 17% on average since FY07 and have outstripped urban wages. A number of government programs have supported this, including the NREGA (A Massive Scam as Shown on Satyamev Jayate) which provides 100 days of employment to a member of each rural family.

Economic Researchers have found evidence to support the hypothesis that inflation has been higher in states where NREGA has been implemented to a greater degree. Not only are (more…)

As we get closer to elections, political parties are stitching together alliances to help their electoral prospects. The BJP seems to be ahead in the race reinforcing their image of being the frontrunner in the polls. It has also belied some apprehensions that Narendra Modi being at the helm would prevent allies from joining the party. Key alliances formed by the BJP include (a) Bihar (LJP, RLSP), (b) Tamil Nadu (5 Parties), and (c) Haryana (HJC). It is also likely to announce an alliance in Andhra Pradesh with TDP, as per media reports.

Why Tamilnadu Alliance is Shot in the Arm of BJP ?
BJP announced a major alliance in the (more…)

Claris Lifesciences has announced an offer for buyback of 9.25 million shares (representing 14.49% of equity share capital) at a price of Rs250 per share on a proportionate basis through the tender offer process. The stock is currently trading at Rs189.

The objective of the Buy Back is to return surplus cash to the Equity Shareholders of the Company. In accordance with Regulation 6 of the Buy (more…)